DrugCard
Teams use DrugCard to automate local and global medical literature screening without reading every journal cover to cover. The service monitors 2200+ local journals across 146+ countries, handles 100+ languages, and bundles modules like Simple Search, Regulatory Intelligence, an adverse event database, and eCTDlight. Marketing Authorization Holders, CROs, and PV freelancers are the audiences highlighted on the homepage.
Where generic literature databases stop at keyword alerts, DrugCard focuses on local-language journals and scanned print copies. The vendor claims proprietary OCR reaches up to 99% accuracy on average-quality scans and that customers see 50-70% time savings versus manual screening, with the homepage citing 60% savings and up to 3 minutes per article instead of 35.
Teams buy through demo requests rather than self-serve checkout. DrugCard also sells LQPPV, signal management, PSUR, ICSR, PSMF, and risk management services for orgs that want outsourced pharmacovigilance help alongside the software.
Monitors 2200+ local medical journals across 146+ countries with support for 100+ languages
Proprietary OCR handles poorly scanned hard-copy journals with up to 99% keyword recognition accuracy
DrugCard Platform automates local literature screening with email alerts plus weekly summary reports
Simple Search, Regulatory Intelligence, Adverse Event Database, and eCTDlight modules extend beyond core screening
Customer feedback cites 50-70% time savings, and the homepage lists 60% savings versus human-only screening
New country journal packs typically onboard in 2-3 weeks according to the site FAQ
Covers 2200+ local journals in 100+ languages, a niche most general research databases skip
Vendor-reported 50-70% screening time savings frees PV staff for signal detection and PSUR work
Bundles software with optional LQPPV, PSUR, ICSR, and signal management services
No public pricing; every plan starts with a demo or sales conversation
Heavy enterprise focus may be overkill for small teams with simple literature needs
Platform login lives at app.drug-card.io, separate from the marketing site navigation
What is DrugCard?
DrugCard is a pharmacovigilance automation platform for local and global literature monitoring. DrugCard combines software modules with optional PV services for CROs, MAHs, and freelancers.
How many languages does DrugCard support?
DrugCard supports 100+ languages for local medical journal screening. The homepage also lists 146+ countries of journal coverage and 2200+ continuously monitored local journals.
How much time can DrugCard save?
DrugCard reports 50-70% time savings based on customer feedback, and the homepage highlights 60% savings compared with a human-only approach. The FAQ example says a 35-minute manual read drops to about 3 minutes with DrugCard.
Can DrugCard read scanned journal PDFs?
Yes. DrugCard uses proprietary OCR technology that the vendor says delivers up to 99% accuracy on average-quality scanned texts, including poorly scanned hard copies customers submit.
Does DrugCard send screening alerts?
DrugCard emails instant notifications when a new drug mention appears and sends weekly summary reports for audit preparation. Those alerts are part of the local literature monitoring workflow described on the homepage.
Who is DrugCard built for?
DrugCard targets CROs managing multiple PV projects, Marketing Authorization Holders running in-house screening, and freelancers who want to automate journal reads. Each audience has a dedicated section on the homepage.
How do you buy DrugCard?
DrugCard sells through demo and meeting requests rather than public self-serve pricing. Prospects can use the Request a Demo form on drug-card.io or schedule a HubSpot meeting linked from the homepage.

